Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obstructive Lung Diseases

  Free Subscription


Articles published in Eur Respir J

Retrieve available abstracts of 195 articles:
HTML format



Single Articles


    November 2021
  1. ABDEL-AZIZ MI, Vijverberg SJH, Neerincx AH, Brinkman P, et al
    A multi-omics approach to delineate sputum microbiome-associated asthma inflammatory phenotypes.
    Eur Respir J. 2021 Nov 25. pii: 13993003.02603-2021.
    PubMed    


  2. REINKE SN, Naz S, Chaleckis R, Gallart-Ayala H, et al
    Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study.
    Eur Respir J. 2021 Nov 25. pii: 13993003.01733-2021.
    PubMed     Abstract available


  3. JAYARAM L, Vandal AC, Chang C, Lewis C, et al
    Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial.
    Eur Respir J. 2021 Nov 18. pii: 13993003.02184-2021.
    PubMed     Abstract available


  4. MIKUS MS, Kolmert J, Andersson LI, Ostling J, et al
    Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.
    Eur Respir J. 2021 Nov 4. pii: 13993003.00142-2021.
    PubMed     Abstract available


  5. STRIDSMAN C, Vanfleteren LEGW, Konradsen JR, Axelsson Fisk S, et al
    Predictors of severe COVID-19 in a registry-based Swedish cohort of patients with COPD.
    Eur Respir J. 2021;58.
    PubMed    


  6. OLIVER BG
    Food for thought: why is there more airway smooth muscle in asthma?
    Eur Respir J. 2021;58.
    PubMed    


  7. MANNINO DM
    Asthma, COPD and their overlap: coexistence or something more?
    Eur Respir J. 2021;58.
    PubMed    


    October 2021
  8. PIJNENBURG MW, Frey U, De Jongste JC, Saglani S, et al
    Childhood asthma- pathogenesis and phenotypes.
    Eur Respir J. 2021 Oct 28. pii: 13993003.00731-2021.
    PubMed     Abstract available


  9. ELSEY L, Pantin T, Holmes LJ, Tavernier G, et al
    Outcomes over the first two years of treatment with mepolizumab in severe asthma.
    Eur Respir J. 2021 Oct 28. pii: 13993003.01313-2021.
    PubMed     Abstract available


  10. SIBILA O, Laserna E, Shoemark A, Perea L, et al
    Heterogeneity of treatment response in bronchiectasis clinical trials.
    Eur Respir J. 2021 Oct 21. pii: 13993003.00777-2021.
    PubMed     Abstract available


  11. REDDEL HK, Bacharier LB, Bateman ED, Brightling CE, et al
    Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes.
    Eur Respir J. 2021 Oct 19. pii: 13993003.02730-2021.
    PubMed     Abstract available


  12. CHAN R, Misirovs R, Lipworth B
    Repeatability of impulse oscillometry in patients with severe asthma.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01679-2021.
    PubMed    


  13. SUN Y, Xia PF, Xie J, Mustieles V, et al
    Association of blood trihalomethane concentrations with asthma in U.S. adolescents: nationally representative cross-sectional study.
    Eur Respir J. 2021 Oct 8. pii: 13993003.01440-2021.
    PubMed     Abstract available


  14. PORSBJERG C, Maitland-van der Zee AH, Brusselle G, Canonica GW, et al
    3TR: a pan-European cross-disease research consortium aimed at improving personalised biological treatment of asthma and COPD.
    Eur Respir J. 2021;58.
    PubMed    


  15. CHANG AB, Boyd J, Bush A, Grimwood K, et al
    Children's Bronchiectasis Education Advocacy and Research Network (Child-BEAR-Net): an ERS Clinical Research Collaboration on improving outcomes of children and adolescents with bronchiectasis.
    Eur Respir J. 2021;58.
    PubMed    


  16. KEIR HR, Chalmers JD
    IL-6 trans-signalling: how Haemophilus surfs the NET to amplify inflammation in COPD.
    Eur Respir J. 2021;58.
    PubMed    


  17. PETOUSI N, Wooden A, Russell REK
    A new piece in the puzzle: the eosinophil and the development of COPD.
    Eur Respir J. 2021;58.
    PubMed    


  18. WINSLOW S, Odqvist L, Diver S, Riise R, et al
    Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  19. PHILIP J, Collins A, Smallwood N, Chang YK, et al
    Referral criteria to palliative care for patients with respiratory disease: a systematic review.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  20. PARK HY, Chang Y, Kang D, Hong YS, et al
    Blood eosinophil counts and the development of obstructive lung disease: the Kangbuk Samsung Health Study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  21. HIRAI K, Tanaka A, Sato H, Sato Y, et al
    Effect of surgical mask on exercise capacity in COPD: a randomised crossover trial.
    Eur Respir J. 2021;58.
    PubMed    


    September 2021
  22. MIURA S, Iwamoto H, Omori K, Yamaguchi K, et al
    Accelerated decline in lung function in adults with a history of remitted childhood asthma.
    Eur Respir J. 2021 Sep 29. pii: 13993003.00305-2021.
    PubMed     Abstract available


  23. BATEMAN ED, Price DB, Wang HC, Khattab A, et al
    Short-acting beta2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.
    Eur Respir J. 2021 Sep 24. pii: 13993003.01402-2021.
    PubMed     Abstract available


  24. BUSBY J, Matthews JG, Chaudhuri R, Pavord ID, et al
    Factors affecting adherence with treatment advice in a clinical trial of patients with severe asthma.
    Eur Respir J. 2021 Sep 24. pii: 13993003.00768-2021.
    PubMed     Abstract available


  25. PANAGOU P, Tzilas V, Bouros D
    "Dynamic (C dyn) lung compliance in non-smokers with asthma and fixed, non-reversible airflow obstruction" ERJ 2021 58: 2004400.
    Eur Respir J. 2021 Sep 24. pii: 13993003.02361-2021.
    PubMed    


  26. AGARWAL R, Muthu V, Sehgal IS, Dhooria S, et al
    A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma.
    Eur Respir J. 2021 Sep 9. pii: 13993003.01787-2021.
    PubMed     Abstract available


  27. VAN HULST G, Jorssen J, Jacobs N, Henket M, et al
    Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma.
    Eur Respir J. 2021 Sep 2. pii: 13993003.00935-2021.
    PubMed     Abstract available


  28. GARCIA-LARSEN V
    Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon?
    Eur Respir J. 2021;58.
    PubMed    


  29. RUFFLES T, Lipworth B, Mukhopadhyay S
    Considerations of a real life pragmatic clinical trial in adolescent asthma.
    Eur Respir J. 2021;58.
    PubMed    


  30. VAN BOVEN JFM, Dierick BJH, Usmani OS
    When biology meets behaviour: can medication adherence mask the contribution of pharmacogenetic effects in asthma?
    Eur Respir J. 2021;58.
    PubMed    


  31. LOUIS R, Louis G, Bonhomme O
    NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice.
    Eur Respir J. 2021;58.
    PubMed    


  32. BAFADHEL M, Barnes N, Bourke SC, Compton C, et al
    A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial.
    Eur Respir J. 2021;58.
    PubMed    


    August 2021
  33. ROFFEL MP, Boudewijn IM, van Nijnatten JLL, Faiz A, et al
    Identification of asthma associated microRNAs in bronchial biopsies.
    Eur Respir J. 2021 Aug 26. pii: 13993003.01294-2021.
    PubMed     Abstract available


  34. KEIR HR, Shoemark A, Huang JTJ, Chalmers JD, et al
    SPLUNC1 is a novel marker of disease severity and airway infection in bronchiectasis.
    Eur Respir J. 2021 Aug 19. pii: 13993003.01840-2021.
    PubMed    


  35. SUNJAYA AP, Allida SM, Di Tanna GL, Jenkins CR, et al
    Asthma and Coronavirus Disease 2019 Risk: a systematic review and meta-analysis.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01209-2021.
    PubMed     Abstract available


  36. WU M, Xie J, Wang Y, Tian Y, et al
    Greenness and eosinophilic asthma: Findings from the UK Biobank.
    Eur Respir J. 2021 Aug 12. pii: 13993003.01597-2021.
    PubMed    


  37. AFSHAR-MOHAJER N, Wu TD, Shade R, Brigham E, et al
    Obesity, tidal volume, and pulmonary deposition of fine particulate matter in children with asthma.
    Eur Respir J. 2021 Aug 12. pii: 13993003.00209-2021.
    PubMed     Abstract available


  38. IZQUIERDO JL, Soriano JB
    Biologics may have a beneficial effect in asthma patients with COVID-19.
    Eur Respir J. 2021;58.
    PubMed    


  39. ZEDER K, Avian A, Bachmaier G, Douschan P, et al
    Elevated pulmonary vascular resistance predicts mortality in COPD patients.
    Eur Respir J. 2021;58.
    PubMed    


  40. HARTLEY T, Lane ND, Steer J, Elliott MW, et al
    The Noninvasive Ventilation Outcomes (NIVO) score: prediction of in-hospital mortality in exacerbations of COPD requiring assisted ventilation.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  41. BROXTERMAN RM, Wagner PD, Richardson RS
    Exercise training in COPD: muscle O2 transport plasticity.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    July 2021
  42. WECKMANN M, Bahmer T, Bulow Sand JM, Rank Ronnow S, et al
    COL4A3 is degraded in allergic asthma and degradation predicts response to anti-IgE therapy.
    Eur Respir J. 2021 Jul 29. pii: 13993003.03969-2020.
    PubMed     Abstract available


  43. BUSSE WW, Paggiaro P, Munoz X, Casale TB, et al
    Impact of baseline patient characteristics on dupilumab efficacy in type 2 asthma.
    Eur Respir J. 2021 Jul 29. pii: 13993003.04605-2020.
    PubMed    


  44. HAN YY, Forno E, Bacharier LB, Phipatanakul W, et al
    Vitamin D supplementation, lung function, and asthma control in children with asthma and low vitamin D levels.
    Eur Respir J. 2021 Jul 29. pii: 13993003.00989-2021.
    PubMed    


  45. CORREN J, Katelaris CH, Castro M, Maspero JF, et al
    Effect of exacerbation history on clinical response to dupilumab in moderate-severe uncontrolled asthma.
    Eur Respir J. 2021 Jul 15. pii: 13993003.04498-2020.
    PubMed     Abstract available


  46. WARK PA, Pathinayake PS, Eapen MS, Sohal SS, et al
    Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00920-2021.
    PubMed    


  47. SUNDE RB, Thorsen J, Pedersen CT, Stokholm J, et al
    Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood.
    Eur Respir J. 2021 Jul 8. pii: 13993003.00453-2021.
    PubMed     Abstract available


  48. RAMAKRISHNAN S, Couillard S
    Antibiotics for asthma attacks: masking uncertainty.
    Eur Respir J. 2021;58.
    PubMed    


  49. MILNE S, Li X, Yang CX, Leitao Filho FS, et al
    Inhaled corticosteroids downregulate SARS-CoV-2-related genes in COPD: results from a randomised controlled trial.
    Eur Respir J. 2021;58.
    PubMed    


  50. YOUNG RP, Scott RJ
    Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?
    Eur Respir J. 2021;58.
    PubMed    


  51. LEVY L, Huszti E, Berra G, Renaud-Picard B, et al
    The accuracy of forced vital capacity for diagnosing restrictive allograft syndrome and mixed phenotype of chronic lung allograft dysfunction.
    Eur Respir J. 2021;58.
    PubMed    


  52. RUTTING S, Badal T, Wallis R, Schoeffel RE, et al
    Long-term variability of oscillatory impedance in stable obstructive airways disease.
    Eur Respir J. 2021;58.
    PubMed    


  53. SCHENK P, Spiel AO, Huttinger F, Gmeiner M, et al
    Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


  54. EVANGELOPOULOS D, Chatzidiakou L, Walton H, Katsouyanni K, et al
    Personal exposure to air pollution and respiratory health of COPD patients in London.
    Eur Respir J. 2021;58.
    PubMed     Abstract available


    June 2021
  55. MOORE WC, Kornmann O, Humbert M, Poirier C, et al
    Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study).
    Eur Respir J. 2021 Jun 25. pii: 13993003.00396-2021.
    PubMed     Abstract available


  56. KRAFT M, Brusselle G, Mark FitzGerald J, Pavord ID, et al
    Patient characteristics, biomarkers, and exacerbation risk in severe, uncontrolled asthma.
    Eur Respir J. 2021 Jun 10. pii: 13993003.00413-2021.
    PubMed     Abstract available


  57. THURSTON GD, Lee A
    Evidence of air pollution exposure and new asthma onset: further justification for cleaner air.
    Eur Respir J. 2021;57.
    PubMed    


  58. WEATHERALL M
    Improving adherence to asthma medications: same-old, same-old?
    Eur Respir J. 2021;57.
    PubMed    


  59. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  60. KUNISAKI KM, Sin DD
    Methylxanthines in COPD: yes to caffeine, no to theophylline.
    Eur Respir J. 2021;57.
    PubMed    


  61. HULL JH, Jackson AR, Ranson C, Brown F, et al
    The benefits of a systematic assessment of respiratory health in illness-susceptible athletes.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  62. JENKINS CR, Wen FQ, Martin A, Barnes PJ, et al
    The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  63. SANTOS LD, Antunes KH, Muraro SP, de Souza GF, et al
    TNF-mediated alveolar macrophage necroptosis drives disease pathogenesis during respiratory syncytial virus infection.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  64. BENINCASA G, DeMeo DL, Glass K, Silverman EK, et al
    Epigenetics and pulmonary diseases in the horizon of precision medicine: a review.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    May 2021
  65. JENDZJOWSKY N, Laing A, Malig M, Matyas J, et al
    Long-term modulation of airway remodeling in severe asthma following bronchial thermoplasty.
    Eur Respir J. 2021 May 28. pii: 13993003.00622-2021.
    PubMed     Abstract available


  66. BENLALA I, Dournes G, Girodet PO, Benkert T, et al
    Evaluation of bronchial wall thickness in asthma using magnetic resonance imaging.
    Eur Respir J. 2021 May 28. pii: 13993003.00329-2021.
    PubMed     Abstract available


  67. SVERRILD A, Hansen S, Hvidtfeldt M, Clausson CM, et al
    The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM).
    Eur Respir J. 2021 May 28. pii: 13993003.01296-2021.
    PubMed     Abstract available


  68. HAKANSSON KEJ, Backer V, Suppli Ulrik C
    Socioeconomic biases in asthma control and specialist referral of possible severe asthma.
    Eur Respir J. 2021 May 13. pii: 13993003.00741-2021.
    PubMed     Abstract available


  69. JOHANSSON H, Wollmer P, Sundstrom J, Janson C, et al
    Bronchodilator response in FOT parameters in middle-aged adults from SCAPIS - normal values and relation to asthma and wheezing.
    Eur Respir J. 2021 May 6. pii: 13993003.00229-2021.
    PubMed    


  70. BRUGIERE O, Verleden SE
    Putting the spotlight on macrophage-derived cathepsin in the pathophysiology of obliterative bronchiolitis.
    Eur Respir J. 2021;57.
    PubMed    


  71. TAN WC, Bourbeau J, Nadeau G, Wang W, et al
    High eosinophil counts predict decline in FEV1: results from the CanCOLD study.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  72. MORRONE C, Smirnova NF, Jeridi A, Kneidinger N, et al
    Cathepsin B promotes collagen biosynthesis, which drives bronchiolitis obliterans syndrome.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    April 2021
  73. MCLEESE RH, Spinou A, Alfahl Z, Tsagris M, et al
    Psychometrics of HRQoL questionnaires in bronchiectasis: A systematic review and meta-analysis.
    Eur Respir J. 2021 Apr 22. pii: 13993003.00025-2021.
    PubMed     Abstract available


  74. GAILLARD EA, Kuehni CE, Turner S, Goutaki M, et al
    European Respiratory Society clinical practice guidelines for the diagnosis of asthma in children aged 5-16 years.
    Eur Respir J. 2021 Apr 19. pii: 13993003.04173-2020.
    PubMed     Abstract available


  75. DURACK T, Chapman DG, Rutting S, Thamrin C, et al
    Dynamic compliance and reactance in older non-smokers with asthma and fixed airflow obstruction.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04400-2020.
    PubMed    


  76. MARCON A, Locatelli F, Dharmage SC, Svanes C, et al
    The coexistence of asthma and COPD: risk factors, clinical history and lung function trajectories.
    Eur Respir J. 2021 Apr 16. pii: 13993003.04656-2020.
    PubMed     Abstract available


  77. ESTEVES P, Blanc L, Celle A, Dupin I, et al
    Crucial role of fatty acid oxidation in asthmatic bronchial smooth muscle remodelling.
    Eur Respir J. 2021 Apr 8. pii: 13993003.04252-2020.
    PubMed     Abstract available


  78. LUCCHETTI D, Santini G, Perelli L, Ricciardi-Tenore C, et al
    Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients.
    Eur Respir J. 2021 Apr 1. pii: 13993003.03024-2020.
    PubMed    


  79. TALAEI M, Hughes DA, Mahmoud O, Emmett PM, et al
    Dietary intake of vitamin A, lung function, and incident asthma in childhood.
    Eur Respir J. 2021 Apr 1. pii: 13993003.04407-2020.
    PubMed     Abstract available


  80. SPITZER C, Ewert R, Volzke H, Frenzel S, et al
    Childhood maltreatment and lung function: findings from the general population.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    March 2021
  81. HIGBEE DH, Nava GW, Kwong ASF, Dodd JW, et al
    The impact of asthma on mental health & wellbeing during COVID-19 lockdown.
    Eur Respir J. 2021 Mar 25. pii: 13993003.04497-2020.
    PubMed    


  82. BRUSSELLE G, Nicolini G, Santoro L, Guastalla D, et al
    BDP/formoterol MART asthma exacerbation benefit increases with blood eosinophil level.
    Eur Respir J. 2021 Mar 18. pii: 13993003.040982020.
    PubMed    


  83. PRICE OJ, Kucera KL, Price HM, Drezner JA, et al
    Asthma-related sudden death in athletes: A retrospective analysis of the U.S. NCCSIR database (1982-2018).
    Eur Respir J. 2021 Mar 7. pii: 13993003.00088-2021.
    PubMed    


  84. WEE LE, Conceicao EP, Tan JY, Sim JXY, et al
    Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore.
    Eur Respir J. 2021 Mar 2. pii: 13993003.04493-2020.
    PubMed    


  85. KNIHTILA HM, Kelly RS, Brustad N, Huang M, et al
    Maternal 17q21 genotype influences prenatal vitamin D effects on offspring asthma/recurrent wheeze.
    Eur Respir J. 2021 Mar 2. pii: 13993003.02012-2020.
    PubMed     Abstract available


  86. BOTTLE A, Quint J
    COPD: still an unpredictable journey.
    Eur Respir J. 2021;57.
    PubMed    


  87. CHAPMAN DG, King GG
    To recline is to relax? Not when you have COPD!
    Eur Respir J. 2021;57.
    PubMed    


  88. COLAK Y
    Cardiac disease from accelerated FEV1 decline and acute exacerbations: time to rethink comorbidities in COPD.
    Eur Respir J. 2021;57.
    PubMed    


  89. CELLI B, Locantore N, Yates JC, Bakke P, et al
    Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  90. WANG G, Hallberg J, Um Bergstrom P, Janson C, et al
    Assessment of chronic bronchitis and risk factors in young adults: results from BAMSE.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  91. WING K, Williamson E, Carpenter JR, Wise L, et al
    Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  92. DI CAMPLI MP, Azouz A, Assabban A, Scaillet J, et al
    The mononuclear phagocyte system contributes to fibrosis in post-transplant obliterans bronchiolitis.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  93. TIEW PY, Dicker AJ, Keir HR, Poh ME, et al
    A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  94. ELBEHAIRY AF, Faisal A, McIsaac H, Domnik NJ, et al
    Mechanisms of orthopnoea in patients with advanced COPD.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  95. WHITTAKER HR, Bloom C, Morgan A, Jarvis D, et al
    Accelerated FEV1 decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    February 2021
  96. MASOLI M, Lanario JW, Hyland ME, Menzies-Gow A, et al
    The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference (MCID).
    Eur Respir J. 2021 Feb 25. pii: 13993003.00300-2021.
    PubMed    


  97. REDDEL HK, Vestbo J, Agusti A, Anderson GP, et al
    Heterogeneity within and between physician-diagnosed asthma and/or COPD: NOVELTY cohort.
    Eur Respir J. 2021 Feb 25. pii: 13993003.03927-2020.
    PubMed     Abstract available


  98. CHANG AB, Fortescue R, Grimwood K, Alexopoulou E, et al
    Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis.
    Eur Respir J. 2021 Feb 11. pii: 13993003.02990-2020.
    PubMed     Abstract available


  99. BUSSE WW, Kraft M, Rabe KF, Deniz Y, et al
    Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03393-2020.
    PubMed     Abstract available


  100. WANG R, Alahmadi F, Niven R, Fowler SJ, et al
    Same-day repeatability of fractional exhaled nitric oxide in severe asthma.
    Eur Respir J. 2021 Feb 4. pii: 13993003.03391-2020.
    PubMed    


  101. REDDEL HK
    Reply: About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    PubMed    


  102. FERRETTI S, Gelsomino M, Miceli Sopo S
    About the recommendation of the GINA strategy report on asthma step 1.
    Eur Respir J. 2021;57.
    PubMed    


  103. PENN RB
    Honing in on the effectors of oxidative stress in the asthmatic lung: oxidised phosphatidylcholines.
    Eur Respir J. 2021;57.
    PubMed    


  104. BRUSASCO C, Corradi F, Di Domenico A, Raggi F, et al
    Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure.
    Eur Respir J. 2021;57.
    PubMed    


  105. STOCKLEY RA
    COPD frequent exacerbators: time for the recycle bin?
    Eur Respir J. 2021;57.
    PubMed    


  106. JANSON C, Lisspers K, Stallberg B, Johansson G, et al
    Osteoporosis and fracture risk associated with inhaled corticosteroid use among Swedish COPD patients: the ARCTIC study.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  107. CASS SP, Yang Y, Xiao J, McGrath JJC, et al
    Current smoking status is associated with reduced sputum immunoglobulin M and G expression in COPD.
    Eur Respir J. 2021;57.
    PubMed    


  108. SADATSAFAVI M, McCormack J, Petkau J, Lynd LD, et al
    Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
    Eur Respir J. 2021;57.
    PubMed     Abstract available


    January 2021
  109. ROGLIANI P, Ritondo BL, Calzetta L
    Triple therapy in uncontrolled asthma: a network meta-analysis of Phase III studies.
    Eur Respir J. 2021 Jan 28. pii: 13993003.04233-2020.
    PubMed     Abstract available


  110. GIAM YH, Shoemark A, Chalmers JD
    Neutrophil dysfunction in bronchiectasis: an emerging role for immunometabolism.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03157-2020.
    PubMed     Abstract available


  111. TALAEI M, Sdona E, Calder PC, Jones LR, et al
    Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype, and incident asthma.
    Eur Respir J. 2021 Jan 28. pii: 13993003.03633-2020.
    PubMed     Abstract available


  112. BEAULIEU D, Attwe A, Breau M, Lipskaia L, et al
    Phospholipase A2-Receptor 1 Promotes Lung-Cell Senescence and Emphysema in Obstructive Lung Disease.
    Eur Respir J. 2021 Jan 28. pii: 13993003.00752-2020.
    PubMed     Abstract available


  113. RUFFLES T, Jones CJ, Palmer C, Turner S, et al
    Asthma prescribing according to Arg16Gly beta-2 genotype: a randomised trial in adolescents.
    Eur Respir J. 2021 Jan 21. pii: 13993003.04107-2020.
    PubMed     Abstract available


  114. MAGNAYE KM, Naughton KA, Huffman J, Hogarth DK, et al
    A-to-I editing of miR-200b-3p in airway cells is associated with moderate-to-severe asthma.
    Eur Respir J. 2021 Jan 14. pii: 13993003.03862-2020.
    PubMed     Abstract available


  115. MURRAY CS, Lucas SJ, Blakey J, Kaplan A, et al
    A real-life comparative effectiveness study into the addition of antibiotics to the management of asthma exacerbations in primary care.
    Eur Respir J. 2021 Jan 8. pii: 13993003.03599-2020.
    PubMed     Abstract available


  116. SIBILA O
    Reducing Pseudomonas sputum density in bronchiectasis.
    Eur Respir J. 2021;57.
    PubMed    


  117. MOMEN NC, Liu X
    Maternal antibiotic use during pregnancy and asthma in children: population-based cohort study and sibling design.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  118. PLEASANTS RA, Tilley SL, Hickey AJ, Usmani OS, et al
    User-life of ICS/LABA inhaler devices should be considered when prescribed as relievers.
    Eur Respir J. 2021;57.
    PubMed    


  119. SUNADOME H, Sato S, Matsumoto H, Murase K, et al
    Similar distribution of peripheral blood eosinophil counts in European and East Asian populations from investigations of large-scale general population studies: the Nagahama Study.
    Eur Respir J. 2021;57.
    PubMed    


  120. LIN J, Huang N, Li J, Liu X, et al
    Cross-reactive antibodies against dust mite-derived enolase induce neutrophilic airway inflammation.
    Eur Respir J. 2021;57.
    PubMed     Abstract available


  121. GUIBERT N, Guilleminault L, Lepage B, Heluain V, et al
    Bronchial thermoplasty in patients with dynamic hyperinflation: results from the proof-of-concept HEAT trial.
    Eur Respir J. 2021;57.
    PubMed    


    December 2020
  122. EGER K, Bel EH
    Asthma and COVID-19: do we finally have answers?
    Eur Respir J. 2020 Dec 30. pii: 13993003.04451-2020.
    PubMed    


  123. MOORE A, Preece A, Sharma R, Heaney LG, et al
    A randomised controlled trial of the effect of a connected inhaler system on medication adherence in uncontrolled asthmatic patients.
    Eur Respir J. 2020 Dec 17. pii: 13993003.03103-2020.
    PubMed     Abstract available


  124. KRUG J, Kiefer A, Koelle J, Vuorinen T, et al
    TLR 7/8 regulates Type I and Type III Interferon Signalling in RV1b induced Allergic Asthma.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01562-2020.
    PubMed     Abstract available


  125. LIU S, Jorgensen JT, Ljungman P, Pershagen G, et al
    Long-term exposure to low-level air pollution and incidence of asthma: the ELAPSE project.
    Eur Respir J. 2020 Dec 10. pii: 13993003.030992020.
    PubMed     Abstract available


  126. LONGO C, Blais L, Brownell M, Quail JM, et al
    Association between asthma control trajectories in preschoolers and disease remission.
    Eur Respir J. 2020 Dec 10. pii: 13993003.01897-2020.
    PubMed     Abstract available


  127. HERNANDEZ-PACHECO N, Vijverberg SJ, Herrera-Luis E, Li J, et al
    Genome-wide association study of asthma exacerbations despite inhaled corticosteroids use.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03388-2020.
    PubMed     Abstract available


  128. CHO PSP, Fletcher HV, Patel IS, Turner RD, et al
    Cough Hypersensitivity and Suppression in Chronic Obstructive Pulmonary Disease.
    Eur Respir J. 2020 Dec 10. pii: 13993003.03569-2020.
    PubMed     Abstract available


  129. O'BYRNE PM, Pavord ID
    A golden age of asthma research.
    Eur Respir J. 2020;56.
    PubMed    


  130. WALTERS EH, Shukla SD, Ward C
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    PubMed    


  131. HIGHAM A, Singh D
    Stability of eosinophilic inflammation in COPD bronchial biopsies.
    Eur Respir J. 2020;56.
    PubMed    


    November 2020
  132. CRICHTON ML, Dudgeon EK, Shoemark A, Chalmers JD, et al
    Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure.
    Eur Respir J. 2020 Nov 19. pii: 13993003.03156-2020.
    PubMed     Abstract available


  133. FARNE H, Singanayagam A
    Why asthma might surprisingly protect against poor outcomes in COVID-19.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03045-2020.
    PubMed    


  134. IZQUIERDO JL, Almonacid C, Gonzalez Y, Del Rio-Bermudez C, et al
    The Impact of COVID-19 on Patients with Asthma.
    Eur Respir J. 2020 Nov 5. pii: 13993003.03142-2020.
    PubMed     Abstract available


  135. MERKUS PJ, Pijnenburg MW
    Diagnosing asthma in children or adolescents/young adults? It is time for a change! How timing is everything, also in clinical practice.
    Eur Respir J. 2020;56.
    PubMed    


  136. WHITMORE GA, Aaron SD
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    PubMed    


  137. PERRET JL, Vicendese D, Dharmage SC
    Population-based case-finding to identify airflow obstruction in symptomatic adults at high risk for asthma and COPD.
    Eur Respir J. 2020;56.
    PubMed    


  138. SAHANIC S, Boehm A, Pizzini A, Sonnweber T, et al
    Assessing self-medication for obstructive airway disease during COVID-19 using Google Trends.
    Eur Respir J. 2020;56.
    PubMed    


    October 2020
  139. O'BYRNE PM, Reddel HK, Beasley R
    The Management of Mild Asthma.
    Eur Respir J. 2020 Oct 22. pii: 13993003.03051-2020.
    PubMed     Abstract available


  140. YAN Q, Forno E, Herrera-Luis E, Pino-Yanes M, et al
    A genome-wide association study of severe asthma exacerbations in Latino children and adolescents.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02693-2020.
    PubMed     Abstract available


  141. HANON S, Brusselle G, Deschampheleire M, Louis R, et al
    COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry.
    Eur Respir J. 2020 Oct 22. pii: 13993003.02857-2020.
    PubMed    


  142. PAPI A, Braithwaite I, Ebmeier S, Hancox B, et al
    Budesonide-formoterol reliever therapy in intermittent versus mild persistent asthma.
    Eur Respir J. 2020 Oct 15. pii: 13993003.03064-2020.
    PubMed    


  143. ILMARINEN P, Pardo A, Tuomisto LE, Vahatalo I, et al
    Long-term prognosis of new adult-onset asthma in obese patients.
    Eur Respir J. 2020 Oct 8. pii: 13993003.01209-2020.
    PubMed     Abstract available


  144. HOLZ O, Waschki B, Watz H, Kirsten A, et al
    Breath volatile organic compounds and inflammatory markers in adult asthma patients - negative results from the ALLIANCE cohort.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02127-2020.
    PubMed    


  145. KERMANI NZ, Pavlidis S, Xie J, Sun K, et al
    Instability of sputum molecular phenotypes in U-BIOPRED severe asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.01836-2020.
    PubMed    


  146. O'NEILL C, Gibson PG, Heaney LG, Upham JW, et al
    The cost-effectiveness of azithromycin in reducing exacerbations in uncontrolled asthma.
    Eur Respir J. 2020 Oct 2. pii: 13993003.02436-2020.
    PubMed     Abstract available


  147. QUINN M, Turner AM
    Modernising case finding for alpha1-antitrypsin deficiency by DNA sequencing of COPD patients.
    Eur Respir J. 2020;56.
    PubMed    


  148. GLANVILLE AR
    Pseudomonas and risk factor mitigation for chronic lung allograft dysfunction.
    Eur Respir J. 2020;56.
    PubMed    


  149. CAVIEDES I, Soto R, Herth F
    The determination of ventilatory inefficiency at rest in COPD: the expected parameter.
    Eur Respir J. 2020;56.
    PubMed    


    September 2020
  150. CHOI YJ, Park JY, Lee HS, Suh J, et al
    Effect of Asthma and Asthma Medication on the Prognosis of Patients with COVID-19.
    Eur Respir J. 2020 Sep 25. pii: 13993003.02226-2020.
    PubMed     Abstract available


  151. ASHER MI, Garcia-Marcos L, Pearce NE, Strachan DP, et al
    "Trends in worldwide asthma prevalence".
    Eur Respir J. 2020 Sep 24. pii: 13993003.02094-2020.
    PubMed     Abstract available


  152. DAI X, Bui D, Perret JL, Lowe A, et al
    Exposure to household air pollution over 10 years is related to asthma and lung function decline.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00602-2020.
    PubMed     Abstract available


  153. THOMPSON CA, Eslick SR, Berthon BS, Wood LG, et al
    Asthma medication use in obese and healthy weight asthma: systematic review/meta-analysis.
    Eur Respir J. 2020 Sep 17. pii: 13993003.00612-2020.
    PubMed     Abstract available


  154. PASCOE CD, Jha A, Ryu MH, Ragheb M, et al
    Allergen inhalation generates pro-inflammatory oxidised phosphatidylcholine associated with airway dysfunction.
    Eur Respir J. 2020 Sep 3. pii: 13993003.00839-2020.
    PubMed     Abstract available


  155. CALVERLEY PMA, Farre R
    Oscillometry: old physiology with a bright future.
    Eur Respir J. 2020;56.
    PubMed    


    August 2020
  156. CONNELL D, Shah A
    The contribution of Aspergillus fumigatus to COPD exacerbations: a "sensitive" topic.
    Eur Respir J. 2020;56.
    PubMed    


  157. NANZER AM, D'Ancona G, Kelly PA, Jackson DJ, et al
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    PubMed    


  158. LIPWORTH B, Chan R, Kuo CR
    Diagnosing adrenal insufficiency using ACTH stimulation test.
    Eur Respir J. 2020;56.
    PubMed    


    July 2020
  159. JOHNSON MJ, Ekstrom M, Currow DC
    Observational studies and "the eye of the beholder".
    Eur Respir J. 2020;56.
    PubMed    


  160. KUGELMAN A
    High-flow nasal cannula therapy: can it be recommended as initial or rescue care for infants with moderate bronchiolitis in the paediatric ward?
    Eur Respir J. 2020;56.
    PubMed    


  161. CHALMERS JD, Miravitlles M
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    PubMed    


  162. AGUSTI A
    Withdrawal of inhaled corticosteroids in COPD.
    Eur Respir J. 2020;56.
    PubMed    


  163. TRINKMANN F, Watz H, Herth FJF
    Why do we still cling to spirometry for assessing small airway function?
    Eur Respir J. 2020;56.
    PubMed    


  164. BOURDIN A, Gamez AS, Vachier I, Crestani B, et al
    LAM is another small airway disease: lessons from microCT.
    Eur Respir J. 2020;56.
    PubMed    


  165. ARSHAD SH, Kurukulaaratchy R, Zhang H, Hodgekiss C, et al
    Assessing small airway function for early detection of lung function impairment.
    Eur Respir J. 2020;56.
    PubMed    


    June 2020
  166. RUSSELL REK, Wang K
    Finding the true prevalence of obstructive lung disease: two steps forward and one step back.
    Eur Respir J. 2020;55.
    PubMed    


  167. ROCHE N, Tonia T, Miravitlles M, Vaccaro V, et al
    Expanding the spectrum of European Respiratory Society official scientific documents: short documents complement clinical practice guidelines, statements and technical standards.
    Eur Respir J. 2020;55.
    PubMed    


    May 2020
  168. DURAND P, Guiddir T, Kyheng C, Blanc F, et al
    A Randomised Trial of High-Flow Nasal Cannula in Infants with Moderate Bronchiolitis.
    Eur Respir J. 2020 May 7. pii: 13993003.01926-2019.
    PubMed     Abstract available


  169. STOLZ D, Miravitlles M
    The right treatment for the right patient with COPD: lessons from the IMPACT trial.
    Eur Respir J. 2020;55.
    PubMed    


  170. VEDEL-KROGH S
    The search for the "healthy" blood eosinophil count.
    Eur Respir J. 2020;55.
    PubMed    


  171. DE JONG CCM, Pedersen ESL, Mozun R, Goutaki M, et al
    A clinically significant bronchodilator response in children: how should it be measured?
    Eur Respir J. 2020;55.
    PubMed    


  172. GUEZGUEZ F, Ben Saad H
    What constitutes a "clinically significant" bronchodilator response in children?
    Eur Respir J. 2020;55.
    PubMed    


  173. HALPIN DMG, Dransfield MT, Han MK, Jones CE, et al
    The effect of exacerbation history on outcomes in the IMPACT trial.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  174. SCHEERENS C, Faes K, Pype P, Beernaert K, et al
    Earlier palliative home care is associated with patient-centred medical resource utilisation and lower costs in the last 30 days before death in COPD: a population-level decedent cohort study.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  175. MATHIOUDAKIS AG, Bikov A, Foden P, Lahousse L, et al
    Change in blood eosinophils following treatment with inhaled corticosteroids may predict long-term clinical response in COPD.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  176. HARTL S, Breyer MK, Burghuber OC, Ofenheimer A, et al
    Blood eosinophil count in the general population: typical values and potential confounders.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  177. JOGDAND P, Siddhuraj P, Mori M, Sanden C, et al
    Eosinophils, basophils and type 2 immune microenvironments in COPD-affected lung tissue.
    Eur Respir J. 2020;55.
    PubMed     Abstract available


  178. THULBORN SJ, Cane JL, Connolly C, Borg C, et al
    Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD.
    Eur Respir J. 2020;55.
    PubMed    


  179. LEONG P, Ruane LE, Phyland D, Koh J, et al
    Inspiratory vocal cord closure in COPD.
    Eur Respir J. 2020;55.
    PubMed    


    April 2020
  180. BEASLEY R, Braithwaite I, Semprini A, Kearns C, et al
    Achieving the balance between evidence and simplicity.
    Eur Respir J. 2020;55.
    PubMed    


  181. LIPWORTH B, Kuo CR, Chan R
    Making simple things complicated using anti-inflammatory reliever therapy.
    Eur Respir J. 2020;55.
    PubMed    


  182. DIVO MJ
    The adipose tissue and lung health: like many things in life, the extremes are not good.
    Eur Respir J. 2020;55.
    PubMed    


    March 2020
  183. SUISSA S, Ernst P
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


  184. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Avoiding immortal time bias in observational studies.
    Eur Respir J. 2020;55.
    PubMed    


  185. COLAK Y, Nordestgaard BG, Vestbo J, Lange P, et al
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    PubMed    


  186. RENNARD SI
    Outcomes consequent to "early" COPD for interventional studies.
    Eur Respir J. 2020;55.
    PubMed    


  187. POLVERINO F, Soriano JB
    Small airways and early origins of COPD: pathobiological and epidemiological considerations.
    Eur Respir J. 2020;55.
    PubMed    


    November 2019
  188. BOUCLY A, Morelot-Panzini C, Garcia G, Weatherald J, et al
    Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension.
    Eur Respir J. 2019 Nov 26. pii: 13993003.02108-2018.
    PubMed     Abstract available


  189. SUISSA S, Dell'Aniello S, Gonzalez AV, Ernst P, et al
    Inhaled corticosteroid use and the incidence of lung cancer in COPD.
    Eur Respir J. 2019 Nov 19. pii: 13993003.01720-2019.
    PubMed     Abstract available


    September 2019
  190. SPIRO SG, Shah PL, Rintoul RC, George J, et al
    Sequential screening for lung cancer in a high-risk group: randomised controlled trial.
    Eur Respir J. 2019 Sep 19. pii: 13993003.00581-2019.
    PubMed     Abstract available


  191. ROCHE N, Anzueto A, Bosnic Anticevich S, Kaplan A, et al
    The importance of real-life research in respiratory medicine: manifesto of the Respiratory Effectiveness Group: Endorsed by the International Primary Care Respiratory Group and the World Allergy Organization.
    Eur Respir J. 2019;54.
    PubMed    


    August 2019
  192. KRISHNA MT, Subramanian A, Adderley NJ, Zemedikun D, et al
    Allergic Diseases and Long Term Risk of Autoimmune Disorders: longitudinal cohort study and cluster analysis.
    Eur Respir J. 2019 Aug 14. pii: 13993003.00476-2019.
    PubMed     Abstract available


    April 2019
  193. PICHL A, Sommer N, Bednorz M, Seimetz M, et al
    Riociguat for treatment of pulmonary hypertension in COPD - a translational study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.02445-2018.
    PubMed     Abstract available


  194. RAYMAKERS AJN, Sadatsafavi M, Sin DD, FitzGerald JM, et al
    Inhaled corticosteroids and the risk of lung cancer in chronic obstructive pulmonary disease (COPD): a population-based cohort study.
    Eur Respir J. 2019 Apr 7. pii: 13993003.01257-2018.
    PubMed     Abstract available


    December 2018
  195. NATHAN SD, Barbera JA, Gaine SP, Harari S, et al
    Pulmonary hypertension in chronic lung disease and hypoxia.
    Eur Respir J. 2018 Dec 13. pii: 13993003.01914-2018.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: